An update on nitrate tolerance: can it be avoided?

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Postgraduate medical journal

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/pgmj.68.805.857PMID 1494507PMCID PMC2399487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitroglycerin ointment effective for seven hours in severe angina pectoris.

  2009cited by this paper
• Mechanisms of nitrate tolerance: A review

  2005cited by this paper
• A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction

  2004cited by this paper
• Effect of nitroglycerin on blood rheology in healthy subjects

  2004cited by this paper
• Human pharmacological studies of a new transdermal system containing nitroglycerin

  2004cited by this paper
• N-Acetylcysteine potentiates coronary artery dilation by nitroglycerin

  1990cited by this paper
• LONG‐TERM THERAPEUTIC EFFICACY WITH ONCE‐DAILY ISOSORBIDE‐5‐MONONITRATE (IMDUR®)

  1990cited by this paper
• What causes tolerance to nitroglycerin? The 100 year old mystery continues.

  1990cited by this paper
• The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.

  1990cited by this paper
• Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.

  1990cited by this paper
• Chronic administration of N-acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris.

  1990cited by this paper
• Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule.

  1989cited by this paper
• Antianginal efficacy of a new nitroglycerin patch.

  1989cited by this paper
• Effect of intracoronary and intravenous propranolol on human coronary arteries.

  1989cited by this paper
• N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers.

  1989cited by this paper
• Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.

  1989cited by this paper
• Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction.

  1989cited by this paper
• Limited usefulness of intermittent nitroglycerin patches in stable angina.

  1989cited by this paper
• Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.

  1989cited by this paper
• Interval therapy to avoid nitrate tolerance: paradise regained?

  1989cited by this paper
• Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.

  1988cited by this paper
• Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.

  1988cited by this paper
• Pilot incapacitation and aircraft accidents.

  1988cited by this paper
• Prevention of tolerance to nitroglycerin patches by overnight removal.

  1987cited by this paper
• Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.

  1987cited by this paper
• In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries.

  1987cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• The treatment of angina pectoris with nitroglycerin plasters. A multicenter study involving 6,986 patients.

  1987cited by this paper
• Nitrate tolerance: the lack of effect of N-acetylcysteine.

  1987cited by this paper
• Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

  1987cited by this paper
• Prevention and reversal of nitrate tolerance in patients with congestive heart failure.

  1987cited by this paper
• Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.

  1987cited by this paper
• The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.

  1986cited by this paper
• Recent studies on transdermal nitroglycerin patch efficacy.

  1986cited by this paper
• A double-blind multicenter, cross-over general practice study of glyceryltrinitrate delivered by a transdermal therapeutic system in stable angina pectoris

  1986cited by this paper
• Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure

  1986cited by this paper
• Effects of sulfhydryl reagents on nitroglycerin-induced relaxation of bovine coronary artery.

  1986cited by this paper
• A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration.

  1986cited by this paper
• Mode of action of nitrates with regard to vasodilatation and tolerance.

  1986cited by this paper
• Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

  1986cited by this paper
• Some issues concerning transdermal nitroglycerin patches.

  1986cited by this paper
• Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

  1986cited by this paper
• Desensitization to nitroglycerin in vascular smooth muscle from rat and human.

  1986cited by this paper
• Nitrate tolerance.

  1986cited by this paper
• Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.

  1985cited by this paper
• Sustained effects of transdermal nitroglycerin in patients with angina pectoris.

  1985cited by this paper
• The mechanism of cGMP-induced relaxation in vascular smooth muscle.

  1985cited by this paper
• Prevention and Reversal of Tolerance to Nitroglycerine with N‐Acetylcysteine

  1985cited by this paper
• Nitroderm® TTS versus oral isosorbide dinitrate: a double blind trial in patients with angina pectoris

  1985cited by this paper
• Hemodynamic effects of nitroglycerin and long-acting nitrates.

  1985cited by this paper
• Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.

  1985cited by this paper
• Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.

  1985cited by this paper
• Sustained effects of transdermal nitroglycerin in patients with angina pectoris.

  1985cited by this paper
• Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.

  1985cited by this paper
• Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.

  1984cited by this paper
• Prophylactic antiarrhythmic therapy in acute myocardial infarction.

  1984cited by this paper
• Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.

  1984cited by this paper
• Antianginal effects of nitroglycerin patches.

  1984cited by this paper
• Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.

  1984cited by this paper
• Pharmacokinetic determinants of nitrate action.

  1984cited by this paper
• Comparison of the prophylactic anti-anginal effect of two doses of nitroderm TTS in out-patients with stable angina pectoris

  1984cited by this paper
• Intravenous isosorbide dinitrate in acute left ventricular failure--a dose--response study.

  1983cited by this paper
• Tolerance to isosorbide dinitrate: rate of development and reversal.

  1983cited by this paper
• Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.

  1983cited by this paper
• Tolerance development during isosorbide dinitrate treatment: can it be circumvented?

  1983cited by this paper
• Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.

  1983cited by this paper
• Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.

  1983cited by this paper
• [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].

  1982cited by this paper
• Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.

  1982cited by this paper
• Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.

  1982cited by this paper
• Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

  1981cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Tolerance to the Circulatory Effects of Oral Isosorbide Dinitrate: Rate of Development and Cross–tolerance to Glyceryl Trinitrate

  1980cited by this paper
• Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing.

  1978cited by this paper
• Purification and properties of a protein required for sodium azide activation of guanylate cyclase.

  1977cited by this paper
• The Renin–Angiotensin System during Controlled Hypotension with Sodium Nitroprusside

  1977cited by this paper
• Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.

  1977cited by this paper
• Effect of Sustained Release Nitroglycerin Capsules On Anginal Frequency and Exercise Capacity: a Double-Blind Evaluation

  1977cited by this paper
• Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity: a double-blind evaluation.

  1977cited by this paper
• Hemodynamics and Antianginal Effects of High Dose Oral Isosorbide Dinitrate After Chronic Use

  1977cited by this paper
• The Pharmacological and Biochemical Interaction of Organic Nitrates with Sulfhydryls: Possible Correlations with the Mechanism for Tolerance Development, Vasodilation, and Mitochondrial and Enzyme Reactions

  1975cited by this paper
• Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.

  1975cited by this paper
• Sulfhydryl requirement for relaxation of vascular smooth muscle.

  1973cited by this paper
• Mechanism of tolerance development to organic nitrates.

  1973cited by this paper
• The cause, relief and prevention of headaches arising from contact with dynamite.

  1946cited by this paper
• THE EFFECTS OF NITROGLYCERIN ON THOSE ENGAGED IN ITS MANUFACTURE

  1914cited by this paper
• TOLERANCE TO NITROGLYCERIN.

  1905cited by this paper
• ON THE USE OF NITRITE OF AMYL IN ANGINA PECTORIS.

  1867cited by this paper

• Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents

  2018cites this paper
• Intravenous Vasodilator Therapy in Congestive Heart Failure

  2003cites this paper
• Extending a Bayesian analysis of the two-period crossover to allow for baseline measurements.

  1994cites this paper
• Nitrates in silent ischemia

  1994cites this paper
• Antianginal Effect of Isosorbide-5-Mononitrate Given as Monotherapy in Angina Pectoris

  1993cites this paper
• Isosorbide Dinitrate Solution Spray in Exercise-Induced Angina Pectoris

  1993cites this paper